Compare Expedia Group Inc (EXPE) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Expedia Group Inc vs Tenet Healthcare Corporation — how do they compare? Expedia Group Inc trades at $270.98 (market cap $32.06B), while Tenet Healthcare Corporation trades at $198.74 (market cap $16.57B). The key difference: Expedia Group Inc is the larger of the two by market cap, and Expedia Group Inc pays a 0.66% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| EXPE | THC | |
|---|---|---|
Market Cap | $32.06B | $16.57B |
Sector | Consumer Cyclical | Health |
52-Week High | $301.31 | $244.80 |
52-Week Low | $178.06 | $148.38 |
Enterprise Value | $30.97B | $26.81B |
Dividend Yield | 0.66% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Expedia Group (EXPE) trades at $264.76, down 0.57% on the day, with a bullish technical outlook supported by moving averages. The company shows strong fundamentals with revenue growth to $14.73B in 2025 and consistent earnings beats, including Q1 2026 EPS of $1.96 versus $1.41 expected. Recent developments include a strategic partnership with Allegiant Travel and positive analyst coverage highlighting growth potential. Valuation metrics include a P/E of 23.6 and P/S of 2.29, indicating reasonable pricing relative to peers.
The outlook for EXPE is positive, driven by robust travel demand, strategic initiatives, and a consensus price target of $292.09 implying ~10% upside. Key risks include macroeconomic sensitivity affecting travel spending and competitive pressures. Institutional sentiment is bullish with 45% buy ratings, though investors should monitor execution on growth targets and industry cyclicality.
Tenet Healthcare (THC) trades at $198.46, up 8.04% in the last 24 hours, showing strong momentum. The stock is supported by a bullish analyst consensus with a $235.88 price target, while recent earnings have consistently beaten expectations. However, technical indicators signal a bearish short-term trend, with the price currently testing key support levels near $191.
The outlook is positive based on solid fundamentals, including a low P/E of 10 and strong profitability metrics like a 37.87% ROE. Key risks include market volatility ahead of Q2 2026 earnings on July 24 and potential macroeconomic pressures on the healthcare sector. The primary opportunity lies in the stock's attractive valuation relative to its growth and analyst targets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Expedia Group Inc
Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Read more on EXPE →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
